Title Image

PROGRAM

Friday 20 October 2023
HALL A
14:00-15:00 REGISTRATIONS
15:00-16:30 SESSION I: FERTILITY PRESERVATION

Chairs: Alexandros Rodolakis, Nikolaos Vlahos

  • Should we move for fertility preservation to oocyte donation for young women with cancer? When? Nikolaos Vlahos
  • Fertility preservation in oncological patients Alexandros Rodolakis
  • Fertility preservation in endometriosis. When should be offered? Konstantinos Dafopoulos
16:30-18:00 SESSION II: MENOPAUSE
Chairs: Erol Tavmergen, Sophia Kalantaridou

  • Menopause and cardiovascular disease Sophia Kalantaridou
  • Should Androgens be routinely added to menopause treatment and the risk for malignancies? Dinka Pavicic Baldani
  • Should ovarian tissue reimplantation be considered for women to postpone menopause? Antonios Makrigiannakis

Discussion
18:00-18:30 SATELLITE LECTURE I

Chair: Antonios Makrigiannakis

Can AMH predict menopause? Sophia Kalantaridou

Sponsored by Roche Diagnostics
18:30-19:00 COFFEE BREAK
19:00-19:30 KEY NOTE LECTURE I

Chair: Antonios Makrigiannakis

Tissue engineering in reproductive medicine: Where are we? Anis Feki
19:30-20:00 OPENING CEREMONY

Saturday 21 October 2023
HALL A HALL B
09:00-09:30 KEY NOTE LECTURE II

Chairs: Tatjana Motrenko, Omar Sefrioui

  • Genetics and reproduction: everything everywhere, all at once
    Sermon Karen
09:30-11:00 SESSION III: OVARIAN STIMULATION

Chairs:Dimitrios Loutradis, Ioannis Messinis

  • A simplified approach to ovarian stimulation for elective freezing?
    Ioannis Messinis
  • Androgen priming for ovarian stimulation?
    Tatjana Motrenko
  • The type of gonadotrophin for stimulation. Does it matter?
    Basil Tarlantzis
  • The impact of SNPs of FSHR, Ser680Asn, in the Follicular Fluid using four different gonadotrophins preparation, for ovulation induction.
    Dimitrios Loutradis

Discussion

SESSION IV: EMBRYOLOGY I

Chairs: Moncef Benkhalifa, Borut Kovacic

  • Impact of sperm factors on oocytes activation and embryo competency Moncef Benkhalifa
  • Oxidative stress in update infertility Hassan Sallam
  • Sperm preparation for IVF by microfluids Borut Kovacic

Discussion
11:00-11:30 COFFEE BREAK
11:30-13:00 SESSION V: ENDOMETRIUM-IMPLANTATION

Chairs: Antonios Makrigiannakis, Hassan Sallam

  • Why is frozen better than fresh embryo transfer?
     Ege Tavmergen
  • Asherman syndrome : Surgery or Stem cells?
    Anis Feki
  • Why is endometrium hyper-acceptive in recurrent Miscarriage patients?
    Udo Jetsche
  • Recurrent pregnancy loss in ART
    Antonios Makrigiannakis

Discussion

 SESSION VI: EMBRYOLOGY II

Chairs: Borut Kovacic, Moncef Benkhalifa

  • Predictive follicular biomarkers for oocyte quality and clinical outcomes
    Moncef Benkhalifa
  • Testicular or ejaculated sperm in ICSI. Indications and clinical management
    Borut Kovacic
  • Round Spermatid Injection (ROSI): Current Situation
    Halil Ruso

Discussion
13:00-13:30 SATELLITE LECTURE II

Chair: Nikolaos Vlahos

Real World Evidence (RWE) for comparative effectiveness of gonadotropins in ART and the Greek experience with Follitropin alfa in assisted reproduction
Evangelos Makrakis

Sponsored by Merck
13:30-14:00 SATELLITE LECTURE III

Chair: Ioannis Messinis

hCG-driven LH activity: A Reliable ally in ART?
Basil Tarlantzis

Sponsored by Faran
14:00-15:00 LUNCH BREAK
15:00-16:30 SESSION VII: REPRODUCTIVE SURGERY

Chair: Grigorios Grimbizis, Omar Sefrioui

  • Impact of fibroids in ART success to treat and when?
    Erol Tavmergen
  • Cesarean scar disorder:when a niche become a clinical problem?
    Grigorios Grimbizis
  • Removal of Endometriomas before IVF. What is the evidence?
    Omar Sefrioui
  • Adenomyosis: the hidden enemy in ART
    Ege Tavmergen
 ORAL PRESENTATIONS I
16:30-17:00 COFFEE BREAK
17:00-18:30 SESSION VIII: ADD- ONS

Chair: Messinis Ioannis, Dinka Pavicic Baldani

  • Rejuvenating the ovary. Does it help?
    Lucas D. Klentzeris
  • Should we keep doing assisted hatching?
    Borut Kovacic
  • ERA -test what proof do we have?
    Efstratios Kolibianakis
  • Introduction new technologies in IVF: Did it improve the outcome?
    Dinka Pavicic Baldani
 ORAL PRESENTATIONS II
18:30-19:30 SATELLITE SYMPOSIUM I

Debate Moderator: Antonios Makrigiannakis
Age limitation at ART in Greece
Pros. Konstantinos Pantos
Cons. Minas Mastrominas
Panel Committee: Nikolaos Vlahos, Konstantinos Dafopoulos, Marinos Tsirigotis

Sponsored by Fertilland

Sunday 22 October 2023
HALL A
08:00-9:00 ORAL PRESENTATIONS III
09:00-10:30 SESSION IX: EARLY PREGNANCY

Chairs: Petros Drakakis, Hassan Sallam

  • Recurrent pregnancy loss: The latest management guidelines
    Petros Drakakis
  • Diagnosis and treatment of molar pregnancy
    Thomas Vrekoussis
  • Macrophage polarization in the decidua-is this the cause for preeclampsia?
    Udo Jeschke

Discussion
10:30-11:00

SATELLITE LECTURE IV

Chair: Alexandros Velergakis
Vaccination in Pregnancy. The rationale for vaccination to protect pregnant individuals and young infants Ioanna Tsiaousi

Sponsored by Vianex
11.00-11.30 COFFEE BREAK
11:30-12:00 KEY NOTE LECTURE III

Chair: Hassan Sallam, Ioannis Messinis

Implication of advanced maternal age in ART
Luca Gianaroli
12:00-12:30 SATELLITE LECTURE V

Chair: Grigorios Grimbizis

Follicular homocysteine predicts reproductive outcomes in PCOS and responds to dietary interventions
Maurizio Dattillo

Sponsored by Parthenogenesis Hellas
12:30-14:00 SESSION X: Maternal – Fetal Medicine
Chair: Georgios Daskalakis, Peter Drakakis

  • CS or Vaginal delivery in pretern delivery, prior to 32, 28 weeks at gestation? Georgios Daskalakis
  • What week to operate HR gestation (placenta previa, placenta accreta? Nikolaos Vrachnis
  • Twins with asymptomatic mid trimester short cervix. Cerclage? Progesterone? Pessary? Neither? Rasidaki Maria

Discussion
14:00-14.30 CLOSING REMARKS